Provided by Tiger Trade Technology Pte. Ltd.

Novo-Nordisk A/S

46.74
+0.60001.30%
Pre-market: 47.170.4300+0.92%05:11 EDT
Volume:10.91M
Turnover:511.14M
Market Cap:206.73B
PE:11.68
High:47.17
Open:46.35
Low:46.34
Close:46.14
52wk High:64.16
52wk Low:35.12
Shares:4.42B
Float Shares:3.19B
Volume Ratio:0.82
T/O Rate:0.34%
Dividend:1.72
Dividend Rate:3.68%
EPS(TTM):4.00
EPS(LYR):3.62
ROE:59.82%
ROA:18.73%
PB:6.35
PE(LYR):12.91

Loading ...

Your Weight-Loss Drugs Are Next on the Corporate Chopping Block -- WSJ

Dow Jones
·
Jun 07

Tired of nausea or taking a GLP-1 pill every day? These experimental drugs could be better than Zepbound and Wegovy.

Dow Jones
·
Jun 07

BRIEF-Novo Nordisk Says People With Type 2 Diabetes Who Were Increased To Semaglutide 2 Mg Were more likely to achieve greater than 5% weight loss than those who were switched to tirzepatide

Reuters
·
Jun 06

Novo Nordisk - Semaglutide 2 Mg Matches Tirzepatide for Hba1c <7% and Outperforms for ≥5% Weight Loss at 1 Year

THOMSON REUTERS
·
Jun 06

LIVE MARKETS-GLP-1 obesity, diabetes drug market to hit $150 billion in 2030, TD Cowen says

Reuters
·
Jun 05

Veru Enters Supply Agreement With Novo Nordisk for Obesity Study; Shares Surge

MT Newswires Live
·
Jun 05

Veru pact with Novo ‘significant event,’ says Canaccord

TIPRANKS
·
Jun 05

Veru announces clinical supply agreement with Novo Nordisk

TIPRANKS
·
Jun 05

Novo Nordisk Expands Obesity Pipeline With New First‑in‑Human Trial for NNC0113-5840

TIPRANKS
·
Jun 05

Movement Alert|Novo Nordisk Rises 3.12% in Regular Trading, Pharmaceutical Sector Rallies as Oral Wegovy Expands Internationally

Market Focus
·
Jun 04

Novo Nordisk (0QIU) Gets a Hold from Goldman Sachs

TIPRANKS
·
Jun 04

Novo Nordisk A/S Stock Falls Wednesday, Underperforms Market

Dow Jones
·
Jun 04

Dow Jones Top Company Headlines at 7 AM ET: Baidu Sees AI, Chip Business Driving Healthy Revenue Growth | Zara ...

Dow Jones
·
Jun 03

Novo Nordisk's UAE Wegovy Pill Launch an Important Step -- Market Talk

Dow Jones
·
Jun 03

Novo Nordisk Launches Wegovy Oral Weight-Loss Drug in UAE, Its First Market Outside the United States

Deep News
·
Jun 03

EXCLUSIVE-Cigna drops coverage of GLP-1 obesity drugs for its own employees

Reuters
·
Jun 03

Movement Alert|Novo Nordisk Falls 3.17% in Regular Trading, Pharma Sector Weakness Compounded by Worsening Obesity Drug Competition

Market Focus
·
Jun 02

Novo Nordisk Partners With Metabolic for Early Access to Oral Wegovy in UAE

MT Newswires Live
·
Jun 02

Novo Nordisk A/S Stock Falls Monday, Underperforms Market

Dow Jones
·
Jun 02

Moderately bullish activity in Novo Nordisk with shares down 2.99%

TIPRANKS
·
Jun 01